The FDA’s Orthopaedic & Rehabilitation Devices Panel postponed today’s meeting over scheduling conflicts that meant key players couldn’t attend.
The meeting was convened to discuss a possible reclassification of shortwave diathermy devices, which are used to therapeutically heat tissue with an electric current with applications in joint inflammation treatments and physiotherapy.
The FDA is considering pushing shortwave diathermy devices to Class III status, to require premarket approval.
The federal watchdog agency hasn’t announced a new meeting date, but said it will issue a notice in the Federal Register when a new appointment as been made.